Document is current
Any future updates will be listed below
-
Authors
Weldy, Chad S. https://orcid.org/0000-0003-4652-6422
Li, Qin
Monteiro, João P. https://orcid.org/0000-0001-6481-6875
Peters, Tim S. https://orcid.org/0009-0006-4077-8089
Guo, Hongchao
Galls, Drew https://orcid.org/0000-0003-1136-0418
Gu, Wenduo https://orcid.org/0000-0002-3859-3150
Cheng, Paul P. https://orcid.org/0000-0003-3429-2702
Ramste, Markus
Li, Daniel https://orcid.org/0000-0003-1015-6298
Palmisano, Brian T. https://orcid.org/0000-0002-2140-1060
Sharma, Disha https://orcid.org/0000-0001-9486-2709
Worssam, Matthew D. https://orcid.org/0000-0003-4391-5377
Zhao, Quanyi
Bhate, Amruta
Kundu, Ramendra K.
Nguyen, Trieu
Mokry, Michal https://orcid.org/0000-0002-5298-4852
Miller, Clint L. https://orcid.org/0000-0003-4276-3607
van der Laan, Sander W. https://orcid.org/0000-0001-6888-1404
Li, Jin Billy https://orcid.org/0000-0003-0713-1399
Quertermous, Thomas https://orcid.org/0000-0002-7645-9067
- License Information
-
More Information
Article History
Received: 30 October 2024
Accepted: 14 August 2025
First Online: 16 September 2025
Competing interests
: C.S.W. is a consultant for AiRNA Bio and Avidity Biosciences. T.Q. serves on the scientific advisory board for Amgen. J.B.L. is a cofounder of AIRNA Bio and a consultant for Risen Pharma. J.B.L. and Q.L. are named inventors of a patent filed by Stanford University (WO/2023/239781), describing a method related to genetic prediction of RNA editing that relates to human prediction of dsRNA burden. S.W.v.d.L. has received Roche funding for unrelated work. The other authors declare no competing interests.
